MORGAN STANLEY PLC/CALL/MERCK & CO./125/0.1/20.06.25 Share Price

Warrant

DE000MB71H75

Real-time Bid/Ask 15:15:35 08/07/2024 BST
1.24 EUR / 1.25 EUR +5.51% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./125/0.1/20.06.25
Current month-17.48%
1 month-19.18%
Date Price Change
08/07/24 1.25 +5.93%
05/07/24 1.18 +0.85%
04/07/24 1.17 -4.10%
03/07/24 1.22 -6.87%
02/07/24 1.31 -5.07%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 01:37 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB71H7
ISINDE000MB71H75
Date issued 06/06/2023
Strike 125 $
Maturity 20/06/2025 (347 Days)
Parity 10 : 1
Emission price 1.25
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 1.8
Lowest since issue 0.34
Delta0.6x
Omega 5.581
Premium9.55x
Gearing9.3x
Moneyness 1.012
Difference Strike -1.63 $
Difference Strike %-1.30%
Spread 0.01
Spread %0.79%
Theoretical value 1.255
Implied Volatility 23.38 %
Total Loss Probability 47.48 %
Intrinsic value 0.1402
Present value 1.115
Break even 138.61 €
Theta-0.01x
Vega0.04x
Rho0.05x

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus